Our Work · Working GroupS
Rheumatic Heart Disease
A global group of leading experts working to advance knowledge and share best practices in the prevention and treatment of rheumatic heart disease.
Building global momentum in the prevention and treatment of RHD
Connecting experts. Driving change.
Rheumatic heart disease (RHD) affects over 55 million people globally, causing widespread heart valve damage. In order to address the growing prevalence of RHD, H&VC has convened a group of global subject matter experts to conduct workshops, write expert consensus documents, contribute to data registries, and develop a global educational strategy to support the path toward continued research, innovation, and knowledge mobilization in RHD.
Leadership
Meet the group’s leadership
Mayo Clinic, Rochester, MN
UTHealth Houston, Houston, TX
Québec Heart & Lung Institute, Laval University, Québec City, Canada
Learn more from this working group
Podcast · 21 min
Video · 21 min
Rheumatic Heart Disease
Initiatives of the World Heart Federation to Fight Rheumatic Heart Disease
Ami Bhatt and Jagat Narula discuss the World Heart Federation's initiatives to combat Rheumatic Heart Disease and other neglected cardiovascular diseases, advocating for research, government action, and primary care for early detection.
Podcast · 22 min
Video · 22 min
Rheumatic Heart Disease
The Burden of Rheumatic Heart Disease
Ami Bhatt and Jagat Narula discuss the global impact of rheumatic heart disease, its challenges, and ongoing efforts for prevention and treatment.
Winning the Fight Against Rheumatic Heart Valve Disease: Need for a Global Strategy
January 22 & 23, 2026
Course Directors: Philippe Pibarot, Hector Michelina, Jagat Narula
Presentation: Day 1, 8:00
Epidemiology and state of the burden of RHVD worldwide
George Mensah
Co-sponsored by
Watch the video
Explore other working groups
Find out what other H&VC working groups have developed.
Working group
A number of ongoing efforts to build knowledge, develop consensus, and ignite innovation in congenital, adult congenital, and pediatric heart disease.
Explore the group
Working group
This working group is addressing the evolving landscape of clinical trial conduct in the modern era through proof-of-concept projects, publications, and more.
Explore the group
